Content about Amphetamines

May 16, 2010

Target started an ad campaign last year called “Ask Us,” and here the retailer is...

Target started an ad campaign last year called “Ask Us,” and here the retailer is taking a bull's-eye approach against allergies by not only promoting their knowledgeable pharmacists as the friendly neighborhood allergy experts, but also directing consumers as to where they can find the popular decongestant pseudoephedrine.

May 3, 2010

Teva Pharmaceutical Industries had net sales of $3.7 billion in first quarter 2010, a 16%...

March 30, 2010

The Consumer Healthcare Products Association on Tuesday expressed its support for Alabama law HB 528,...

March 22, 2010

Kansas announced last week that it will be the fifth state to implement the National...

March 8, 2010

Missouri has selected the National Precursor Log Exchange to serve as its statewide, real-time electronic...

March 3, 2010

The U.S. District Court for the District of Columbia has upheld a decision by the...

February 17, 2010

The Oklahoma House Public Safety Committee voted on Wednesday to create a state registry of...

January 21, 2010

Four Mississippi legislators earlier this month added the Magnolia State as one of those states...

November 19, 2009

In a nutshell, this program gives any legislative body — state or local — debating...

NEW YORK In a nutshell, this program gives any legislative body — state or local — debating around whether a prescription ought to be required in the purchase of a pseudoephedrine product one less reason to pull the trigger on that decision. And it’s a pretty big reason. Before, the argument could be made that implementing a program like NPLEx was prohibitive because of the associated cost.

October 25, 2009

A white donkey painted in black stripes does not a zebra make. In fact, all...

NEW YORK A white donkey painted in black stripes does not a zebra make. In fact, all you really have is a donkey and a whole lot of paint. Something similar could be said here, because a 92% reduction in PSE sales does not correlate with a 92% reduction in the number of meth addicts cruising the streets.

 

The fact is a 92% reduction in PSE sales doesn’t add up to much of anything positive.

 

 

October 18, 2009

There is a big danger here, and it’s a danger that has less to do...

NEW YORK There is a big danger here, and it’s a danger that has less to do with the neighborhood meth addict in search of pseudoephedrine, and more to do with appropriate access to medicines and who gets to be the gatekeeper to that access. Because not only will a prescription-only PSE restrict consumer access to a legitimate nonprescription cough-cold ingredient, but if successfully mandated by the local government, it also has the potential to limit legitimate access to just about any cost-saving OTC medicine and for just about any reason.

 

September 13, 2009

California and Missouri legislatures may want to take a page out of Louisiana’s playbook in...

NEW YORK California and Missouri legislatures may want to take a page out of Louisiana’s playbook in the pursuit of curbing illicit methamphetamine production. Because here, everyone wins (unless, of course, you’re a meth addict).

 

August 6, 2009

The objective here is closing down clandestine methamphetamine labs. The question is: Who is going...

NEW YORK The objective here is closing down clandestine methamphetamine labs. The question is: Who is going to bear the cost? And the answer, ultimately, is the consumer.

It seems that one of the primary reasons behind legislation like this, which is also under consideration by the California state legislature as well as several local municipalities throughout Missouri, is cost shifting.

July 19, 2009

In the short term, it means pharmacists operating out of one of the 12 or...

NEW YORK In the short term, it means pharmacists operating out of one of the 12 or so pharmacies in Washington, Mo., will need to see a doctor’s prescription before filling any pseudoephedrine requests.

June 4, 2009

Attempting to curtail methamphetamine production by more or less eliminating the precursor ingredient pseudoephedrine from...

NEW YORK Attempting to curtail methamphetamine production by more or less eliminating the precursor ingredient pseudoephedrine from the market is kind of like throwing out the baby with the bathwater. PSE is a legitimate self-care option that is, according to general consensus, more effective than the other cough-cold decongestant on the market — phenylephrine. And restricting access to that self-care option hurts legitimate consumers more than it does meth cooks. But more on that in a second.

 

February 28, 2007

The most significant event that occurred during a soft 2006-2007 cough-and-cold season was the shift of the decongestant pseudoephedrine behind the counter in all 50 states. To be sure, some states still require more strict regulations on the sale of PSE, but at least now PSE is behind the counter in a legislative effort to thwart homegrown methamphetamine makers.

The most significant event that occurred during a soft 2006-2007 cough-and-cold season was the shift of the decongestant pseudoephedrine behind the counter in all 50 states. To be sure, some states still require more strict regulations on the sale of PSE, but at least now PSE is behind the counter in a legislative effort to thwart homegrown methamphetamine makers. Click below to download the PDF of ECRM Cough/Cold 2007.